December 4, 2013 | Israeli biomed company CollPlant, which develops various collagen products for the pharmaceutical industry, has announced the signing of a memorandum of understanding with an unnamed US-based company. According to the agreement, CollPlant will receive a total of $6 million for selling the rights to use their collagen production technology for the cosmetics industry.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments